Skip to main content
Clinical Trials/TCTR20201015003
TCTR20201015003
Recruiting
Phase 4

Clinical outcomes and safety of preoperative non-preserved steroid eye drop in trabeculectomy: A randomised controlled trial

Ratchadapiseksompotch Fund0 sites162 target enrollmentOctober 15, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Due to COVID&#45
Sponsor
Ratchadapiseksompotch Fund
Enrollment
162
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 15, 2020
End Date
November 1, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ratchadapiseksompotch Fund

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \> 40 years old
  • 2\. Patient diagnosed with glaucoma with intraocular pressure at least 20 mmHg despite full medical treatment and plan to treat further with trabeculectomy.
  • 3\. able to understand protocol and condition to be volunteer and capable to visit to every appointment.

Exclusion Criteria

  • 1\. Patients with any current intraocular infection or any history of herpes epithelial keratitis
  • 2\. Patients with current steroid treatment including every route use
  • 3\. Patients with contraindication of using topical corticosteroid or Patients with history of rising intraocular pressure after apply topical corticosteroid
  • 4\. Patients with high intraocular pressure who must have trabeculectomy within 2 weeks
  • 5\. Patients with systemic disease or any contraindication that unable to have trabeculectomy
  • 6\. Patients with pregnancy or expecting pregnancy within 1 year

Outcomes

Primary Outcomes

Not specified

Similar Trials